Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044187
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-08-21
Brief Title:
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia Schizophreniform Disorder Schizoaffective Disorder and Bipolar I Disorder
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company